CALE STREETER: Open Payments
NPI 1639733678 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 12 payments from 7 companies in 2025. Trend: 2023 $200 · 2024 $463 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $156 |
| Neurocrine BioSciences, Inc. | 2 | $153 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| Axsome Therapeutics, Inc. | 1 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Alkermes, Inc. | 1 | $21 |
Products named: VRAYLAR, INGREZZA, COBENFY, Auvelity, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, REXULTI.
Industry payments across OH — which companies pay providers there.
